Amgen CTO David Reese Withholds 556 Shares for Taxes

What Happened
David M. Reese, EVP & Chief Technology Officer of Amgen (AMGN), had 556 shares disposed of to satisfy a tax liability on May 7, 2026. The shares were recorded at $331.11 each for a total value of $184,097. The transaction is coded "F" (payment of exercise price or tax liability), indicating a withholding/covering of taxes rather than an open-market sale.

Key Details

• Transaction date: 2026-05-07; Price per share: $331.11; Total value: $184,097.
• Shares disposed: 556 (reported as "Disposed" to cover taxes).
• Footnote: 350 of the 556 shares are Dividend Equivalents (DEs) credited to unvested RSUs under Amgen's equity plan and paid out in shares on a one-to-one basis upon vesting.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Filing: Report filed 2026-05-11 (timely under the Form 4 two-business-day rule).

Context
This was a routine tax-withholding transaction tied to equity compensation (RSUs/DEs). Such withholdings are administrative — they reduce the insider's share count to cover taxes and do not necessarily indicate a decision to sell shares on the open market.